Results 31 to 40 of about 490,369 (261)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells [PDF]

open access: yesEmerging Infectious Diseases, 2020
Severe acute respiratory syndrome coronavirus 2 did not replicate efficiently in 13 bat cell lines, whereas severe acute respiratory syndrome coronavirus replicated efficiently in kidney cells of its ancestral host, the Rhinolophus sinicus bat, suggesting different evolutionary origins.
Susanna K.P. Lau   +12 more
openaire   +3 more sources

Portable real-time colorimetric LAMP-device for rapid quantitative detection of nucleic acids in crude samples

open access: yesScientific Reports, 2022
Loop-mediated isothermal amplification is known for its high sensitivity, specificity and tolerance to inhibiting-substances. In this work, we developed a device for performing real-time colorimetric LAMP combining the accuracy of lab-based quantitative ...
G. Papadakis   +17 more
doaj   +1 more source

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge

open access: yesMeasurement, 2021
The highly pathogenic MERS-CoV, SARS-CoV and SARS-CoV-2 cause acute respiratory syndrome and are often fatal. These new viruses pose major problems to global health in general and primarily to infection control and public health services. Accurate and selective assessment of MERS-CoV, SARS-CoV and SARS-CoV-2 would assist in the effective diagnosis of ...
Ezhilan, Madeshwari   +2 more
openaire   +2 more sources

Genomic Sequencing and Phylogenomics of Cowpox Virus

open access: yesViruses, 2022
Cowpox virus (CPXV; genus Orthopoxvirus; family Poxviridae) is the causative agent of cowpox, a self-limiting zoonotic infection. CPXV is endemic in Eurasia, and human CPXV infections are associated with exposure to infected animals. In the Fennoscandian
Diana Diaz-Cánova   +5 more
doaj   +1 more source

ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV [PDF]

open access: yesEuropean Respiratory Journal, 2021
ORF8 as an accessory protein of SARS-CoV-2 https://bit.ly ...
openaire   +2 more sources

The design of Indonesian SARS‐CoV‐2 primers based on phylogenomic analysis of the SARS‐CoV‐2 clades

open access: yesIndonesian Journal of Biotechnology, 2022
Molecular detection needs to be augmented for COVID‐19 detection in Indonesia using the PCR method with primer‐based gene analysis. This is necessary because the RNA of the SARS‐CoV‐2 virus, the causative infectious agent of the pandemic, has been ...
Tsania Taskia Nabila   +3 more
doaj   +1 more source

Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2 [PDF]

open access: yes, 2020
The world has given an outbreak alarm in the last two decades, with different members of the coronavirus family infecting people at different times. The spread of the SARS-CoV-2 virus, which last appeared in December 2019 in China and spread rapidly to all over the world, has led the scientific world to studies on these viruses.
İnandıklıoğlu, Nihal, Akkoc, Tunc
openaire   +3 more sources

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2

open access: yesMathematical Biosciences and Engineering, 2021
<abstract> <p>COVID-19 is increasingly affecting human health and global economy. Understanding the fundamental mechanisms of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is highly demanded to develop treatments for COVID-19.
Wenhan Guo   +4 more
openaire   +3 more sources

Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities

open access: yesThoracic Cancer, 2021
Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are ...
Ana Emília Goulart Lemos   +3 more
doaj   +1 more source

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions

open access: yesTrends in Immunology, 2020
The 2019 coronavirus pandemic remains a major public health concern. Neutralizing antibodies (nAbs) represent a cutting-edge antiviral strategy. We focus here on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV, and discuss current progress in antibody research against rampant SARS-CoV-2 infections.
Gavor, Edem   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy